Class IITerminatedVoluntary: Firm initiated
Eagle Spice and Extract Co., Inc.: food recall H-0154-2026
Eagle Spice and Extract Co., Inc. of Brooklyn, NY recalled Eagle Spice Ground Ginger 16 oz. Reason: Contains elevated levels of lead (Pb). The FDA listed it as Class II in its Enforcement Report dated Nov 12, 2025; distribution: Connecticut, New Jersey, New York, Pennsylvania.
Record status as published: Terminated (terminated Apr 30, 2026). openFDA data last updated Oct 21, 2026.
Have this product? Check FDA.gov and your retailer. This page reproduces an FDA Enforcement Report record and is not a public alert. Look for the firm's recall notice on the FDA's recalls page, or ask the store where you bought it what to do. If you think you got sick from a food, contact a health care provider.
Recall details
- Product
- Eagle Spice Ground Ginger 16 oz.
- Product quantity
- 2,476 units
- Reason for recall
- Contains elevated levels of lead (Pb)
- Codes, lots and dates on the package
- Lot: 24907EGGG Best Used by: 01/27/2028
- Distribution pattern
- NY, NJ,CT, PA
- Recalling firm
- Eagle Spice and Extract Co., Inc., Brooklyn, NY
- Classification
- Class II — the FDA uses this class for a situation in which using or being exposed to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
- Voluntary or mandated
- Voluntary: Firm initiated
- How the firm first notified customers
Advertisement
Dates
| Event | Date |
|---|---|
| Recall initiated by the firm | Oct 7, 2025 |
| Classified by the FDA | Nov 4, 2025 |
| Published in the Enforcement Report | Nov 12, 2025 |
| Terminated | Apr 30, 2026 |
Advertisement
OpenPlate shows FDA records as published and does not add new findings. Product names and company names belong to their owners.
Sources
- U.S. Food and Drug Administration, openFDA food enforcement reports, recall number H-0154-2026 (openFDA record). Data provided by the U.S. Food and Drug Administration (https://open.fda.gov).
- Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service. The FDA does not endorse OpenPlate.